Delivery Order SPE2DB22D1106-SPE2DB24FECM8
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract provides Mycophenolate 500 mg tablets, a prescription medication, to DLA Troop Support Medical facilities supporting the Department of Defense. The firm fixed price contract has a potential value of $3,060.10 and a completion date of February 21, 2024. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,857,188 units of the medication Mycophenolate 500 mg tablets, with a ceiling value of $4,891.20. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
- The Defense Logistics Agency awarded a $1,219.46 delivery order to AmerisourceBergen Drug Corp for Mycophenolate 500 mg tablets (100 count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded contract—which includes no set-aside designation—represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken,...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mycophenolate 500 mg tablets. The $2,563.60 Firm Fixed Price contract has a completion date of November 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,267.92 firm fixed-price delivery order covers the procurement of 4,565,231,057 units of the medication Mycophenolate 500 mg Tablet. The contract has an ultimate completion date of July 24, 2024 and does not contain any set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $1,187.55, is for the delivery of 500 mg mycophenolate tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025,...
- This federal contract award, valued at $1,174.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,201,437 units of the medication mycophenolate 500 mg tablets. This is a firm fixed-price delivery order contract with a completion date of May 12, 2025. The contract is not set-aside and was awarded as part of Amerisourcebergen's Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Mycophenolic Acid DR 360 mg Tablets (120 count). The order has a potential value of $1,660.86 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and the product will be delivered from the company's facilities in Conshohocken, Pennsylvania. This delivery order is part of a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg tablets (500-count units) valued at $5,782.51 with firm fixed pricing. This competitively awarded, non-set-aside contract is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger federal...
- This is a $10,782.91 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MYCOPHENOLATE 500 MG TABLET 500S. The contract has an ultimate completion date of June 26, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FECM8Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for Mycophenolate 500 mg tablets in quantities of 100. The contract has a firm fixed price of $1,630.63 and a completion date of March 1, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC allows Amerisourcebergen Drug Corp to deliver a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 2/29/24 |